These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Plasma calcitonin gene-related peptide in diagnosing and predicting paediatric migraine. Fan PC; Kuo PH; Chang SH; Lee WT; Wu RM; Chiou LC Cephalalgia; 2009 Aug; 29(8):883-90. PubMed ID: 19236383 [TBL] [Abstract][Full Text] [Related]
11. Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks. Sarchielli P; Alberti A; Codini M; Floridi A; Gallai V Cephalalgia; 2000 Dec; 20(10):907-18. PubMed ID: 11304026 [TBL] [Abstract][Full Text] [Related]
12. Calcitonin gene-related peptide in blood: is it increased in the external jugular vein during migraine and cluster headache? A review. Tfelt-Hansen P; Le H J Headache Pain; 2009 Jun; 10(3):137-43. PubMed ID: 19330286 [TBL] [Abstract][Full Text] [Related]
13. Increased plasma substance P and CGRP levels, and high ACE activity in migraineurs during headache-free periods. Fusayasu E; Kowa H; Takeshima T; Nakaso K; Nakashima K Pain; 2007 Apr; 128(3):209-214. PubMed ID: 17123735 [TBL] [Abstract][Full Text] [Related]
14. [Frequent episodic migraine and calcitonin gene-related peptide. Influence of treatment with topiramate and zonisamide on levels of the peptide]. Garcia-Estevez DA; Pardo-Parrado M; Silvarrey-Rodriguez S Rev Neurol; 2017 Aug; 65(4):153-156. PubMed ID: 28726232 [TBL] [Abstract][Full Text] [Related]
15. CGRP and VIP levels as predictors of efficacy of Onabotulinumtoxin type A in chronic migraine. Cernuda-Morollón E; Martínez-Camblor P; Ramón C; Larrosa D; Serrano-Pertierra E; Pascual J Headache; 2014 Jun; 54(6):987-95. PubMed ID: 24673487 [TBL] [Abstract][Full Text] [Related]
16. Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally. Gallai V; Sarchielli P; Floridi A; Franceschini M; Codini M; Glioti G; Trequattrini A; Palumbo R Cephalalgia; 1995 Oct; 15(5):384-90. PubMed ID: 8536297 [TBL] [Abstract][Full Text] [Related]
17. Can calcitonin gene-related peptide (CGRP) and pentraxin-3 (PTX-3) be useful in diagnosing acute migraine attack? Vural S; Albayrak L J Recept Signal Transduct Res; 2022 Dec; 42(6):562-566. PubMed ID: 35895308 [TBL] [Abstract][Full Text] [Related]
18. The effects of vitamin D supplementation on interictal serum levels of calcitonin gene-related peptide (CGRP) in episodic migraine patients: post hoc analysis of a randomized double-blind placebo-controlled trial. Ghorbani Z; Rafiee P; Fotouhi A; Haghighi S; Rasekh Magham R; Ahmadi ZS; Djalali M; Zareei M; Razeghi Jahromi S; Shahemi S; Mahmoudi M; Togha M J Headache Pain; 2020 Feb; 21(1):22. PubMed ID: 32093657 [TBL] [Abstract][Full Text] [Related]
19. Feasibility of serum CGRP measurement as a biomarker of chronic migraine: a critical reappraisal. Lee MJ; Lee SY; Cho S; Kang ES; Chung CS J Headache Pain; 2018 Jul; 19(1):53. PubMed ID: 30006780 [TBL] [Abstract][Full Text] [Related]
20. Plasma calcitonin gene-related peptide concentration is comparable to control group among migraineurs and tension type headache subjects during inter-ictal period. Gupta R; Ahmed T; Banerjee B; Bhatia M J Headache Pain; 2009 Jun; 10(3):161-6. PubMed ID: 19277835 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]